Results 31 to 40 of about 29,868 (281)
Immunogenetics of cutaneous lupus erythematosus [PDF]
Current Opinion in Pediatrics, 2016 Purpose of review Systemic lupus erythematosus (SLE) is the prototypic autoimmune condition, often affecting multiple organ systems, including the skin. Cutaneous lupus erythematosus (CLE) is distinct from SLE and may be skin limited or associated with systemic disease.
Aimee O, Hersh +2 more
openaire +2 more sources
Factores asociados al desarrollo de lupus eritematoso sistémico en pacientes con lupus cutáneo [PDF]
, 2020 Importance: Up to 28% of patients with cutaneous lupus erythematosus (CLE) develop systemic lupus erythematosus (SLE). Studies aimed at identifying additional risk factors for progression to systemic disease are scarce and in the case of Latin America ...
Berrío Flórez, Paula Gabriela
core +1 more source
Pathophysiology of cutaneous lupus erythematosus [PDF]
Arthritis Research & Therapy, 2015 AbstractThe pathophysiology of cutaneous lupus erythematosus (CLE) encompasses the complex interactions between genetics, the environment, and cells and their products. Recent data have provided enhanced understanding of these interactions and the mechanism by which they cause disease. A number of candidate genes have been identified which increase the
Achtman, Jordan C, Werth, Victoria P
openaire +2 more sources
, 2018 Capecitabine is a fluoropyrimidine chemotherapy prodrug of 5-fluorouracil (5-FU) used in the treatment of metastatic breast and colorectal cancers.
Darwin, Evan +5 more
core +1 more source
Indian Dermatology Online Journal, 2020 Discoid lupus erythematosus (DLE) is the most common variant of chronic cutaneous lupus erythematosus. Several cases of Blaschko-linear lupus erythematosus, which is regarded as a distinct subtype of lupus erythematosus, have been reported across the ...
Sanjiv Choudhary +3 more
doaj +1 more source
Rheumatologic Manifestations of Patients With Type B Insulin Resistance
Arthritis Care &Research, EarlyView.Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya +4 more
wiley +1 more source
A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
Indian Journal of Ophthalmology, 2013 Cutaneous lupus erythematosus is a previously undiagnosed side-effect of ranibizumab. Here, we present a case of an 82-year-old female Caucasian patient with wet age-related macular degeneration.
Marko Andric +4 more
doaj +1 more source
Pincer nails: an initial and isolated cutaneous manifestation of systemic lupus erythematosus
, 2017 Introduction . Pincer nail deformity due to systemic lupus erythematosus is a rare phenomenon and only three cases have been reported to date. Objective . To present a case of pincer nails in a systemic lupus erythematosus patient and a brief review of
Manoj Karbhari Pawar
core +1 more source
Bullous subacute cutaneous lupus erythematosus
, 2004 We describe a 59-year-old woman, with a history of autoimmune disease and disseminated uterine leiomyosarcoma, who developed a photoaggravated, blistering skin eruption.
McGibbon, D H, Black, M M, Perera, G K
core +1 more source
Arthritis Care &Research, EarlyView.Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh +5 more
wiley +1 more source